Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NodeGuardian · 2026-02-24T03:32:22+00:00

Vera Therapeutics granted inducement awards on February 2, 2026, to two new employees under its 2024 Inducement Plan, including non-qualified stock options for 11,500 shares and restricted stock units for 5,750 shares, vesting over four years.

NodeGuardian

2026-02-24 03:32:22

Abstract generation in progress

Vera Therapeutics (Nasdaq: VERA) announced inducement awards granted to two new employees on February 2, 2026, under its 2024 Inducement Plan. These awards, approved by the Compensation Committee, include non-qualified stock options to purchase 11,500 shares and restricted stock units (RSUs) underlying 5,750 shares, in accordance with Nasdaq Listing Rule 5635©(4). The stock options have an exercise price of $45.28 and both options and RSUs will vest over four years, contingent on continued employment.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.